Une rapide analyse en cours d'Adocia, sans prendre en compte le résultat potentiel du désaccord avec Eli Lilly. Je ne prends en compte uniquement l'analyse graphique.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.